Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
- Reported updated data from the UpRi ovarian cancer expansion cohort further bolstering confidence in UPLIFT registration strategy
- Introduced UP-NEXT, a Phase 3 study of UpRi monotherapy maintenance in platinum-sensitive ovarian cancer
- Presented preclinical…
